Jean-Michel Adam

USPTO Granted Patents = 14 (Patent Applications = 11)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

Reinach, CH (2006 - 2009)
Rosenau, FR (2011 - 2013)
Village-Nuef, FR (2016)
Village-Neuf, FR (2014 - 2021)
Basel, CH (2022)

Company Filing History:

13 out of 4,942

Hoffmann-la Roche Inc.

Years Active: 2006-2025

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12459947 - Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereof (2025-11-04),

2. 12122791 - Process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8- dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one derivatives (2024-10-22),

3. 11390632 - Process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo [1,2-B]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one derivatives (2022-07-19),

4. 11040977 - Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof (2021-06-22),

5. 10246460 - Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof (2019-04-02),

6. 9527810 - (3,4-dichloro-phenyl)-((S)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes (2016-12-27),

7. 9056866 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives (2015-06-16),

8. 8741906 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives (2014-06-03),

9. 8420818 - Process for the preparation of pyrido[2,1-a] isoquinoline derivatives (2013-04-16),

10. 8227613 - Heteroaryl carboxamide derivatives (2012-07-24),

11. 8138175 - Heterocyclyl compounds (2012-03-20),

12. 7872141 - Processes for the manufacture of a pyrrolidine-3,4-dicarboxamide derivative (2011-01-18),

13. 7619101 - Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2H-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one (2009-11-17),

14. 7141648 - Synthesis of cyclosporin analogs (2006-11-28),

Title: Innovation Spotlight: Jean-Michel Adam from Rosenau, FR

Introduction:

Jean-Michel Adam, a prolific inventor based in Rosenau, France, has made significant contributions to the field of pharmaceuticals with a total of 12 patents to his name. His groundbreaking work in synthesizing complex compounds has not gone unnoticed in the world of innovation.

Latest Patents:

Among his latest patents is a revolutionary "Process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo [1,2-B]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one derivatives," which are valuable as pharmaceutically active substances. Additionally, he has patented the "Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereof," showcasing his expertise in intricate chemical processes.

Career Highlights:

Jean-Michel Adam has lent his innovative spirit to renowned companies such as Hoffmann-La Roche Inc. and Isotechnika Inc., where he has spearheaded research and development initiatives that have resulted in groundbreaking patents. His keen eye for detail and passion for advancing pharmaceutical sciences have been instrumental in shaping the industry.

Collaborations:

Throughout his career, Jean-Michel Adam has collaborated with esteemed professionals in the field, including Christophe Pfleger and Fabienne Hoffmann-Emery. These collaborations have fostered a rich exchange of ideas and expertise, contributing to the success of numerous projects and patents.

Conclusion:

In conclusion, Jean-Michel Adam stands as a beacon of innovation in the realm of pharmaceutical inventions. His dedication to pushing the boundaries of chemical synthesis and his exemplary contributions to the field underscore his status as a trailblazing inventor. Rosenau, FR, can proudly claim him as one of its own, as he continues to shape the landscape of pharmaceutical innovations with his remarkable discoveries.

This text is generated by artificial intelligence and may not be accurate.